Literature DB >> 32546663

How much of the future mortality toll of smoking can be avoided?

Kenneth E Warner1, David Mendez2.   

Abstract

OBJECTIVE: To determine how much future smoking-related mortality in the USA can be prevented, recognising that some of that future mortality results from past smoking.
METHODS: Employing a dynamic population simulation model, we estimate smoking's expected mortality burden in the USA, measured as life-years lost (LYL), in a status-quo scenario run from 2018 through 2100. We then estimate LYL attributable to past smoking assuming that all smoking ceases at the end of 2017. We calculate the potential avoidable LYL, which we call the maximum potential reduction in premature mortality (MPRPM), as the difference between the two. We use data from the US Census Bureau, National Vital Statistics Reports, the National Health Interview Survey and Cancer Prevention Study II.
RESULTS: Under status-quo assumptions, smoking will claim 305 million LYL in the US from 2018 to 2100. If all smoking ceased at the end of 2017, past smoking would be responsible for 191.8 million LYL. Thus, avoidable LYL by 2100-the MPRPM-would be 113.2 million, 37% of the expected toll of smoking. A sensitivity analysis finds that were the annual smoking initiation rate 3% instead of 7.8%, the MPRPM would be 13-14% lower. Were the annual permanent smoking cessation rate twice our status-quo estimate of 4.35%, the MPRPM would be 38-39% lower.
CONCLUSIONS: Public health can address only the future toll of future smoking. Smoking's MPRPM is the reduction in the mortality burden of smoking that tobacco control can strive to achieve. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cessation; harm reduction; prevention; smoking caused disease

Year:  2020        PMID: 32546663      PMCID: PMC7738422          DOI: 10.1136/tobaccocontrol-2019-055530

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  9 in total

1.  Adult cigarette smoking prevalence: declining as expected (not as desired).

Authors:  David Mendez; Kenneth E Warner
Journal:  Am J Public Health       Date:  2004-02       Impact factor: 9.308

2.  The financial implications of coverage of smoking cessation treatment by managed care organizations.

Authors:  Kenneth E Warner; David Mendez; Dean G Smith
Journal:  Inquiry       Date:  2004       Impact factor: 1.730

3.  Accuracy and importance of projections from a dynamic simulation model of smoking prevalence in the United States.

Authors:  Kenneth E Warner; David Méndez
Journal:  Am J Public Health       Date:  2012-09-20       Impact factor: 9.308

4.  Vital signs: current cigarette smoking among adults aged ≥18 years--United States, 2005-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-09-09       Impact factor: 17.586

5.  E-cigarettes: Comparing the Possible Risks of Increasing Smoking Initiation with the Potential Benefits of Increasing Smoking Cessation.

Authors:  Kenneth E Warner; David Mendez
Journal:  Nicotine Tob Res       Date:  2019-01-01       Impact factor: 4.244

6.  Has Smoking Cessation Increased? An Examination of the US Adult Smoking Cessation Rate 1990-2014.

Authors:  David Méndez; Jamie Tam; Gary A Giovino; Alexander Tsodikov; Kenneth E Warner
Journal:  Nicotine Tob Res       Date:  2017-11-07       Impact factor: 4.244

7.  Tobacco Product Use Among Adults - United States, 2017.

Authors:  Teresa W Wang; Kat Asman; Andrea S Gentzke; Karen A Cullen; Enver Holder-Hayes; Carolyn Reyes-Guzman; Ahmed Jamal; Linda Neff; Brian A King
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-11-09       Impact factor: 17.586

8.  Tobacco Product Use and Cessation Indicators Among Adults - United States, 2018.

Authors:  MeLisa R Creamer; Teresa W Wang; Stephen Babb; Karen A Cullen; Hannah Day; Gordon Willis; Ahmed Jamal; Linda Neff
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-11-15       Impact factor: 17.586

9.  Potential deaths averted in USA by replacing cigarettes with e-cigarettes.

Authors:  David T Levy; Ron Borland; Eric N Lindblom; Maciej L Goniewicz; Rafael Meza; Theodore R Holford; Zhe Yuan; Yuying Luo; Richard J O'Connor; Raymond Niaura; David B Abrams
Journal:  Tob Control       Date:  2017-10-02       Impact factor: 7.552

  9 in total
  7 in total

1.  E-Cigarettes: A Public Health Threat, Not a Population Health Intervention.

Authors:  Rebekah E Gee; William R Boles; Dean G Smith
Journal:  Am J Public Health       Date:  2021-02       Impact factor: 9.308

2.  A Magic Bullet? The Potential Impact of E-Cigarettes on the Toll of Cigarette Smoking.

Authors:  David Mendez; Kenneth E Warner
Journal:  Nicotine Tob Res       Date:  2021-03-19       Impact factor: 4.244

3.  Impact of Joint Lung Cancer Screening and Cessation Interventions Under the New Recommendations of the U.S. Preventive Services Task Force.

Authors:  Rafael Meza; Pianpian Cao; Jihyoun Jeon; Kathryn L Taylor; Jeanne S Mandelblatt; Eric J Feuer; Douglas R Lowy
Journal:  J Thorac Oncol       Date:  2021-10-12       Impact factor: 20.121

4.  Estimated Prevalence of Smoking and Smoking-Attributable Mortality Associated With Graphic Health Warnings on Cigarette Packages in the US From 2022 to 2100.

Authors:  Jamie Tam; Jihyoun Jeon; James F Thrasher; David Hammond; Theodore R Holford; David T Levy; Rafael Meza
Journal:  JAMA Health Forum       Date:  2021-09-24

5.  Modeling smoking-attributable mortality among adults with major depression in the United States.

Authors:  Jamie Tam; Gemma M J Taylor; Kara Zivin; Kenneth E Warner; Rafael Meza
Journal:  Prev Med       Date:  2020-08-27       Impact factor: 4.018

6.  The ethics of conducting observational tobacco research without providing treatment to people who use tobacco: a case example from South Africa.

Authors:  Gina Kruse; Thando Zulu; Hloniphile Ngubane; Krishna Reddy; Mark Siedner; Nancy A Rigotti; Janet Seeley; Nothando Ngwenya; Emily Wong
Journal:  BMJ Glob Health       Date:  2022-07

7.  The Potential Impact of Widespread Cessation Treatment for Smokers With Depression.

Authors:  Jamie Tam; Kenneth E Warner; Kara Zivin; Gemma M J Taylor; Rafael Meza
Journal:  Am J Prev Med       Date:  2021-07-07       Impact factor: 5.043

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.